InvestorsHub Logo
Followers 17
Posts 735
Boards Moderated 0
Alias Born 02/05/2004

Re: None

Tuesday, 08/18/2015 6:07:45 AM

Tuesday, August 18, 2015 6:07:45 AM

Post# of 345957
Lung Cancer Program Clinical Trials at Dana-Farber / Harvard Cancer Center


Principal Investigator Heist, Rebecca
About Rebecca Heist http://www.dfhcc.harvard.edu/insider/member-detail/member/rebecca-s-heist-md-mph/
Protocol # 14-105
Title A Phase III, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Bavituximab Plus Docetaxel Versus Docetaxel Alone as Second-Line Therapy in Patients with Stage IIIB/IV Non-Squamous Non-Small-Cell Lung Cancer
Phase III
Age Group Adult
DF/HCC Programs
Lung Cancer (includes thoracic cancers)
Secondary Protocol # PPHM 1202
Drugs Involved BAVITUXIMAB; DOCETAXEL; PLACEBO; TAXOTERE (DOCETAXEL)
Status Open

http://www.dfhcc.harvard.edu/research/research-programs/clinical-based-programs/lung-cancer/clinical-trials/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News